NZ314156A - Antipruritic aerosol preparation; contains menthol, camphor and a surfactant - Google Patents
Antipruritic aerosol preparation; contains menthol, camphor and a surfactantInfo
- Publication number
- NZ314156A NZ314156A NZ314156A NZ31415697A NZ314156A NZ 314156 A NZ314156 A NZ 314156A NZ 314156 A NZ314156 A NZ 314156A NZ 31415697 A NZ31415697 A NZ 31415697A NZ 314156 A NZ314156 A NZ 314156A
- Authority
- NZ
- New Zealand
- Prior art keywords
- weight
- aerosolizable
- preparation
- propellant
- itching
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 32
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 title claims description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title claims description 9
- 229940041616 menthol Drugs 0.000 title claims description 9
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 title claims description 7
- 241000723346 Cinnamomum camphora Species 0.000 title claims description 7
- 229960000846 camphor Drugs 0.000 title claims description 7
- 229930008380 camphor Natural products 0.000 title claims description 7
- 239000004094 surface-active agent Substances 0.000 title claims description 6
- 230000001139 anti-pruritic effect Effects 0.000 title description 9
- 239000003908 antipruritic agent Substances 0.000 title description 4
- 239000000443 aerosol Substances 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000003380 propellant Substances 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 10
- -1 fatty acid esters Chemical class 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 208000003251 Pruritus Diseases 0.000 description 21
- 230000007803 itching Effects 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 4
- 241000255925 Diptera Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000001589 sorbitan tristearate Substances 0.000 description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 description 2
- 229960004129 sorbitan tristearate Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XOBOCRSRGDBOGH-UHFFFAOYSA-N 5-phenylnonan-5-ol Chemical compound CCCCC(O)(CCCC)C1=CC=CC=C1 XOBOCRSRGDBOGH-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 241000256173 Aedes albopictus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940027897 ichthammol Drugs 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229960003517 isothipendyl Drugs 0.000 description 1
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical compound C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000028624 response to insect Effects 0.000 description 1
- 230000036185 rubor Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- IAHBIMWHYUOIOH-UHFFFAOYSA-N vanadium hydrochloride Chemical compound Cl.[V] IAHBIMWHYUOIOH-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
<div class="application article clearfix" id="description">
<p class="printTableText" lang="en">314156 <br><br>
Priority Date(s): <br><br>
Complete SpAc:fa-..UGn Fiteci: > <br><br>
m •, <br><br>
tQlM^.SJa <br><br>
PuWfwttion Dato:<..2.4..J.m....J337.. <br><br>
P.O. Joumtl No: <br><br>
NEW ZEALAND PATENTS ACT, 1953 <br><br>
No: Date: <br><br>
N.2. P-.-.Tr^T OFFICE <br><br>
3 0 JAN 1992 <br><br>
^t-Cti;VTD <br><br>
COMPLETE SPECIFICATION <br><br>
AEROSOLIZABLE PREPARATION <br><br>
We, TAISHO PHARMACEUTICAL CO., LTD., a corporation organised under the laws of Japan of 24-1, Takata-3-chome, Toshima-ku, Tokyo, Japan, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: <br><br>
-1 - <br><br>
(followed by page - la -) <br><br>
3141 <br><br>
- Ifl - <br><br>
The present invention relates to an aerosolizable preparation having a distinguished antipruritic effect on itching due to insect biting, athlete's foot, etc. <br><br>
5 Skin response to insect biting develops itching or rubor, including two types, i.e. fast response occurring a few minutes to one hour after the biting and a slow response occurring more than 10 hours to one day after the biting. <br><br>
10 Itching due to the slow response can be suppressed by application of a preparation such as an ordinary ointment containing a local anesthetic or an antipruritic agent, or the like. On the other hand, itching due to the fast response cannot be suppressed 15 fully by application of the above-mentioned preparation or even by cooling due to evaporation of a volatile solvent such as ethanol, etc. as a preparate ingredient, or due to mere spraying of a propellant. <br><br>
An object of the present invention is to 20 provide a preparation having a distinguished antipruritic effect on itching due to the fast response by biting or on itching due to the athlete's foot. <br><br>
As a result of extensive studies, the present inventors found that an aerosolizable preparation 25 comprising a specific surfactant, and specific <br><br>
3? 4 1 <br><br>
- 2 - <br><br>
proportions of menthol and camphor can have such a distinguished antipruritic effect, and established the present invention. <br><br>
The present invention provides an 5 aerosolizable preparation, which comprises a concentrate comprising the following ingredients (A) to (C) in a mixed solvent of water and a lower alcohol, and a propellant: <br><br>
(A) at least one surfactant selected from the 10 group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters; <br><br>
(B) 0.5 to 8% by weight of menthol, on the basis of the concentrate; and <br><br>
(C) 1 to 0.5 part by weight of camphor per 15 part by weight of the menthol. <br><br>
Polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters (A) for use as an ingredient in the concentrate of the present aerosolizable preparation as at least one surfactant are in a paste 20 state or a semi-solid state at room temperature before prepared into the concentrate and are preferably single polyoxyethylene (6) sorbitan monostearate or a mixture of polyoxyethylene (20) sorbitan monostearate, polyoxyethylene (20) sorbitan tristearate and sorbitan 25 monostearate. <br><br>
Surfactant (A) for use as another ingredient in the concentrate of the present aerosolizable preparation is in an amount of 0.5 to 8% by weight, <br><br>
- 3 - <br><br>
314 156 <br><br>
preferably 0.5 to 4% by weight, on the basis of the concentrate. <br><br>
The mixed solvent for use in the concentrate of the present aerosolizable preparation is a mixture of water and a lower alcohol preferably in a ratio of the former to the latter by weight of 30:70 to 70:30. <br><br>
Suitably, the lower alcohol will be one which is commonly used in the art of the present invention, <br><br>
such as ethyl alcohol, isopropyl alcohol, etc. <br><br>
The propellant for use in the present aerosolizable preparation is a liquefied gas, which includes, for example, dimethyl ether, n-butane, <br><br>
10 isobutane, propane or mixtures thereof. A propellant containing at least 80% by weight of dimethyl ether is preferable. The propellant is used in an amount of 40 to <br><br>
80% by weight, preferably 50 to 70% by weight, on the basis of the aerosolizable preparation. <br><br>
15 The present aerosolizable preparation can further contain ingredients usually contained antipruritic and the antifungal agent, such as <br><br>
\ <br><br>
antipruritics (e.g. Crotamiton, Ichthammol, Mochmanmpir'"''^ Thymol acid, etc.); antifungal agents (e.g. Tolnafta^J«7,,,'^<^ <br><br>
20 Miconazole Nitrate, etc.); antihistam.i': agents (e ..g". ' <br><br>
t V" <br><br>
Diphenhydramine, Diphenhydramine hydrochloride, <br><br>
Isothipendyl hydrochloride. Chlorpheniramine maleate, etc.); local anesthetics (e.g. Lidocaine, DibucaineX <br><br>
v hydrochloride, etc.); disinfectants (e.g. potassium 25 iodide, chlorhexidine gluconate, Acrinol, Benzalkonium chloride, etc.); antiphlogistics (e.g. Allantoin, glycyrrhetic acid, methyl salicylate, etc.); antioxidants (e.g. dibutyl hydroxyl toluene, etc.); solubilizing <br><br>
3141 <br><br>
- 4 - <br><br>
agents (e.g. diisopropyl adipate, isopropyl myristate, lactic acid, sodium hydroxide, etc.); perfumes, etc. to such a degree as not to deteriorate the effect of the present aerosolizable preparation. <br><br>
5 The present aerosolizable preparation can be prepared by mixing ingredients together except the propellant with heating and stirring to obtain a liquid homogeneous solution or dispersion and then by filling the solution or dispersion into an aerosol container 10 together with the propellant. <br><br>
According to the present invention, the aerosolizable preparation thus-obtained adheres as a cooling sherbet-like foam when sprayed to the skin surface, and has an excellent antipruritic effect by the 15 specific content ratio of menthol and camphor. <br><br>
The present invention can provide an aerosolizable preparation capable of fastly and continuously releasing itching due to fast response by insect biting or itching due to athlete's foot. 20 Fig. 1 is a diagram showing antipruritic effects of the present aerosolizable preparation and a liquid preparation of Comparative Example 4, where the ordinate shows itching scores and the abscissa shows time in minutes. <br><br>
25 Fig. 2 is a diagram showing antipruritic effects of the aerosolizable preparation of Comparative Examples, where the ordinate shows itching scores and the abscissa shows time in minutes. <br><br>
314 1 <br><br>
- 5 - <br><br>
The present invention will be described in detail below, referring to Examples and Comparative Examples. <br><br>
Example 1 5 Concentrate <br><br>
Ingredients <br><br>
Lidocaine 0.6 g <br><br>
Diphenhydramine 0.3 g <br><br>
Menthol 0.6 g <br><br>
10 Camphor 0.6 g <br><br>
Nikkol TS-10 [trademark of polyoxyethylene (20) sorbitan monostearate] 0.9 g <br><br>
Nikkol TS-30 [Trademark of polyoxyethylene (20) sorbitan tristearate] 0.6 g <br><br>
15 Nikkol SS-10 [trademark of sorbitan monostearate] 0.9 g <br><br>
Ethyl alcohol 10.5 g <br><br>
Purified water to make total 30 ml Propellant <br><br>
20 Dimethyl ether 70 ml <br><br>
The ingredients of the concentrate were mixed together with heating and stirring to obtain a homogeneous solution and filled into an aerosol container together with the propellant to obtain an aerosolizable 25 preparation. <br><br>
- 6 - <br><br>
314 15 6 <br><br>
Examples 2 and 3 and Comparative Examples 1 to 3 <br><br>
Aerosolizable preparations were prepared according to formulations given in "the following Table 1 in the same manner as in Example 1. <br><br>
5 Comparative Example 4 <br><br>
A concentrate was prepared according to the formulation given in the following Table 1 and used as such, as a liquid preparation. <br><br>
• • • # <br><br>
Table 1 <br><br>
Formulation <br><br>
Comp. Ex. 1 <br><br>
Comp. Ex. 2 <br><br>
Example 2 <br><br>
Example 3 <br><br>
Comp. Ex. 3 <br><br>
Comp.Ex.4 <br><br>
Menthol <br><br>
1.2 g <br><br>
2.4 g <br><br>
0.6 g <br><br>
1.2 g <br><br>
- <br><br>
0.6 g <br><br>
Camphor <br><br>
- <br><br>
- <br><br>
0.6 g <br><br>
0.6 g <br><br>
2.4 g <br><br>
0.6 g <br><br>
Nikkol TS-10 <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
Nikkol TS-30 <br><br>
0.6 g <br><br>
0.6 g <br><br>
0.6 g <br><br>
0.6 g <br><br>
0.6 g <br><br>
- <br><br>
Nikkol SS-10 <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
0.9 g <br><br>
- <br><br>
Ethyl alcohol <br><br>
10.5 g <br><br>
10.5 g <br><br>
10.5 g <br><br>
10.5 g <br><br>
10.5 g <br><br>
10.5 g <br><br>
Purified water <br><br>
Total 30 ml <br><br>
Total 30 ml <br><br>
Total 30 <br><br>
Total 30 <br><br>
Total 30 ml <br><br>
Total 30 ml to make: <br><br>
ml ml <br><br>
Dimethyl ether <br><br>
70 ml <br><br>
70 ml <br><br>
70 ml <br><br>
70 ml <br><br>
70 ml <br><br>
- <br><br>
(propellant) <br><br>
CaJ <br><br>
3141 <br><br>
Test Example Testing procedure <br><br>
(1) Put on a rubber glove having an opening, <br><br>
5 mm in diameter, on the back side and put the hand with 5 the rubber glove into a cage provided with a mosquito (Aedes albopictus) therein. <br><br>
(2) Allow the mosquito to bite the back of hand through the opening of the rubber glove. <br><br>
(3) Withdraw the hand from the cage after the 10 mosquito has sucked blood thoroughly, and take off the rubber glove. <br><br>
(4) Spray an appropriate amount (duration of 1-3 seconds at a distance of 3 cm) of each sample (aerosolizable preparations prepared in Examples 2 and 3 <br><br>
15 and Comparative Examples 1 to 3) or apply an appropriate amount of the liquid preparation prepared in Comparative Example 4, when itching exceeds the tolerable limit. <br><br>
(5) Make self-scoring of itching level at every minutes right after the spraying or application <br><br>
20 according to scores given in the following Table 2. <br><br>
Control shows that no treatment has been made at all from the time when itching exceeded the tolerable limit as the starting time. <br><br>
3141 <br><br>
Table 2 <br><br>
Score Itching level <br><br>
0 No itching at all <br><br>
1 Negligeble itching <br><br>
2 Appreciable itching <br><br>
3 Extreme itching <br><br>
Results <br><br>
Results are given in Figs. 1 and 2 on the basis of averages of five subjects. As is evident from Figs. 1 and 2, the present aerosolizable preparations of 5 Examples 2 and 3 had itching levels of score 1 or less, that is, the negligeble itching level, and thus had an effective itching-suppressing effect for people. <br><br></p>
</div>
Claims (4)
- <div class="application article clearfix printTableText" id="claims"> <p lang="en"> - 10 -<br><br> 31 A 156<br><br> WHAT IS CLAIMED IS:<br><br> 1.<br><br> An aerosolizable preparation, which comprises a concentrate comprising the following ingredients (A) to (C) in a mixed solvent of water and a lower alcohol, and a propellant:<br><br> (A) at least one surfactant selected from the group consisting of polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters;<br><br> (B) 0.5 to 8% by weight of menthol, on the basis of the concentrate; and<br><br> (C) 1 to 0.5 part by weight of camphor per part by weight of the menthol.<br><br>
- 2. An aerosolizable preparation according to Claim 1, wherein the propellant contains at least 80% by weight of dimethyl ether.<br><br>
- 3. An aerosolizable preparation according to Claim 1, wherein the propellant is in an amount of 50 to 70% by weight on the basis of the aerosolizable preparation.<br><br>
- 4. An aerosolizable preparation as claimed in claim 1 and substantially as herein described with \<br><br> reference to any example thereof and/or the accompanying figures.<br><br> end of claims<br><br> </p> </div>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ314156A NZ314156A (en) | 1997-01-30 | 1997-01-30 | Antipruritic aerosol preparation; contains menthol, camphor and a surfactant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ314156A NZ314156A (en) | 1997-01-30 | 1997-01-30 | Antipruritic aerosol preparation; contains menthol, camphor and a surfactant |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ314156A true NZ314156A (en) | 1997-07-27 |
Family
ID=19926127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ314156A NZ314156A (en) | 1997-01-30 | 1997-01-30 | Antipruritic aerosol preparation; contains menthol, camphor and a surfactant |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ314156A (en) |
-
1997
- 1997-01-30 NZ NZ314156A patent/NZ314156A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2903708B2 (en) | Aerosol for external use | |
EP0963157B2 (en) | Hydroalcoholic compositions thickened using surfactant/polymer complexes | |
US5776430A (en) | Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol | |
KR100528602B1 (en) | Percutaneous penetration promoter and drug delivery system containing it | |
US5906808A (en) | Process of preparing a topical antimicrobial cleanser | |
US20090098069A1 (en) | Transdermal, alcohol-free, pharmaceutical compositions | |
US8545815B2 (en) | VOC-free compressed gas aerosol composition | |
JP3268500B2 (en) | Pest control agent | |
JP4189047B2 (en) | Pest repellent aerosol | |
JP3881400B2 (en) | Aerosol composition and aerosol-type external preparation | |
JP3038837B2 (en) | Aerosol for skin cooling | |
JPH02264703A (en) | Foaming insect pest repellent aerosol | |
US20060057174A1 (en) | Natural-non-toxic insect repellant | |
NZ314156A (en) | Antipruritic aerosol preparation; contains menthol, camphor and a surfactant | |
WO2004010783A1 (en) | Insect repellant | |
WO1997005858A1 (en) | Aerosol preparation | |
JPS63258405A (en) | External embrocation of aerosol type | |
JPH09110677A (en) | Aerosol preparation | |
JP2005022984A (en) | Insecticidal composition | |
JPH1025203A (en) | Extermination of arthropods and expellent therefor | |
JP3934193B2 (en) | Pest repellent aerosol | |
JP2002114601A (en) | Composition for insectidal aerosol | |
JP2003192503A (en) | Noxious insect-evading composition for human body and noxious insect-evading aerosol composition for human body | |
AU2003281745B2 (en) | Insect repellant | |
CA2593513C (en) | Voc-free compressed gas aerosol compositions |